Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Tagliati

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Frontiers in Neuroscience|April 20, 2016
Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and TechnologiesP Justin Rossi, Aysegul Gunduz, Jack Judy, et al.
The Lancet. Neurology|May 30, 2020
Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled studyJerrold L Vitek, Roshini Jain, Lilly Chen, et al.
Brain : a Journal of Neurology|August 1, 2024
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease studyAna Westenberger, Volha Skrahina, Tatiana Usnich, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Frontiers in Neuroscience|April 20, 2016
Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and TechnologiesP Justin Rossi, Aysegul Gunduz, Jack Judy, et al.
The Lancet. Neurology|May 30, 2020
Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled studyJerrold L Vitek, Roshini Jain, Lilly Chen, et al.
Brain : a Journal of Neurology|August 1, 2024
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease studyAna Westenberger, Volha Skrahina, Tatiana Usnich, et al.
Pageof 9